Daniel E. Bauer
Impact in
- Genetics top 0.2%
- Hemoglobinopathies and Related Disorders
- Virus-based gene therapy research
- Cancer Research top 0.5%
- Cancer, Hypoxia, and Metabolism
Papers in
-
- CRISPR and Genetic Engineering 48
- Epigenetics and DNA Methylation 13
- RNA Interference and Gene Delivery 10
- RNA modifications and cancer 10
- Genetics 41
- Hemoglobinopathies and Related Disorders 39
- Virus-based gene therapy research 10
- Co-authors
- Stuart H. Orkin (40 shared papers)Craig B. Thompson (6 shared papers)Matthew C. Canver (23 shared papers)Georgia Hatzivassiliou (3 shared papers)Charalambos Andreadis (2 shared papers)Fangping Zhao (2 shared papers)Luca Pinello (21 shared papers)Jing Zeng (14 shared papers)
- Journals
- Blood (30 papers)Nature Genetics (4 papers)Bioinformatics (3 papers)Nature Communications (3 papers)Nature (3 papers)
- Partner nations
- United StatesJapanUnited Kingdom
In The Last Decade
Daniel E. Bauer
106 papers receiving 9.5k citations
Daniel E. Bauer's Hit Papers
Peers
Comparison fields: 5 of 137
- Genetics 2.0k
- Cancer Research 1.9k
- Business and International Management 261
- Molecular Biology 7.2k
- Hematology 1.0k
Countries citing papers authored by Daniel E. Bauer
This map shows the geographic impact of Daniel E. Bauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel E. Bauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel E. Bauer more than expected).
Fields of papers citing papers by Daniel E. Bauer
This network shows the impact of papers produced by Daniel E. Bauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel E. Bauer. The network helps show where Daniel E. Bauer may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel E. Bauer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 111 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Akt Stimulates Aerobic Glycolysis in Cancer Cells Hit paper breakdown → | 2004 | 1179 |
| 2 | ATP citrate lyase inhibition can suppress tumor cell growth Hit paper breakdown → | 2005 | 830 |
| 3 | Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity Hit paper breakdown → | 2020 | 677 |
| 4 | BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis Hit paper breakdown → | 2015 | 621 |
| 5 | An Erythroid Enhancer of BCL11A Subject to Genetic Variation Determines Fetal Hemoglobin Level Hit paper breakdown → | 2013 | 461 |
| 6 | 2005 | 419 | |
| 7 | An APOBEC3A-Cas9 base editor with minimized bystander and off-target activities Hit paper breakdown → | 2018 | 339 |
| 8 | Direct Promoter Repression by BCL11A Controls the Fetal to Adult Hemoglobin Switch Hit paper breakdown → | 2018 | 323 |
| 9 | 2012 | 282 | |
| 10 | 2016 | 268 | |
| 11 | 2014 | 264 | |
| 12 | 2020 | 208 | |
| 13 | 2013 | 178 | |
| 14 | 2019 | 165 | |
| 15 | 2012 | 146 | |
| 16 | 2004 | 143 | |
| 17 | 2016 | 140 | |
| 18 | 2012 | 132 | |
| 19 | Assessing and advancing the safety of CRISPR-Cas tools: from DNA to RNA editing Hit paper breakdown → | 2023 | 129 |
| 20 | Improving prime editing with an endogenous small RNA-binding protein Hit paper breakdown → | 2024 | 126 |
About Daniel E. Bauer
Daniel E. Bauer is a scholar working on Molecular Biology, Genetics, Genetics, Hematology and Pediatrics, Perinatology and Child Health, having authored 111 papers that have together received 9.6k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (48 papers), Hemoglobinopathies and Related Disorders (39 papers), Erythrocyte Function and Pathophysiology (14 papers), Epigenetics and DNA Methylation (13 papers), Prenatal Screening and Diagnostics (13 papers), RNA Interference and Gene Delivery (10 papers), Virus-based gene therapy research (10 papers) and RNA modifications and cancer (10 papers). The work is most often cited by research in Genetics (2.0k citations), Cancer Research (1.9k citations), Business and International Management (261 citations), Molecular Biology (7.2k citations) and Hematology (1.0k citations). Daniel E. Bauer has collaborated with scholars based in United States, Japan and United Kingdom. Frequent co-authors include Stuart H. Orkin, Craig B. Thompson, Matthew C. Canver, Georgia Hatzivassiliou, Charalambos Andreadis, Fangping Zhao, Luca Pinello, Jing Zeng, Marian H. Harris and David R. Plas. Their work appears in journals such as Blood, Nature Genetics, Bioinformatics, Nature Communications and Nature.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.